8-K
Current Report
ALNYLAM PHARMACEUTICALS, INC. Filed Acc 0001628280-25-055084
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading alny-20251202.htm…